Chapter 29
References
1. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8369-74.
Frattaroli J, Weidner G, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll PR, Ornish D. Clinical Events in Prostate Cancer Lifestyle Trial: Results From Two Years of Follow-Up. Urology. 2008 Jul 2. [Epub ahead of print]
Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA. Genomic counter-stress changes induced by the relaxation response.
PLoS ONE. 2008 Jul 2;3(7):e2576.
2. Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer.
Integr Cancer Ther. 2003 Jun;2(2):120-38.
Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J. 2008 Jun 3;7:17.
Block KI, Constantinou A, Hilakivi-Clarke L, Hughes C, Tripathy D, Tice JA.
Point-counterpoint: soy intake for breast cancer patients.Integr Cancer Ther. 2002 Mar;1(1):90-100.
Palshof T, Mouridsen HT, Daehnfeldt JL. Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials. Recent Results Cancer Res. 1980;71:185-9.
3.
Cooper JS,
Pajak TF,
Rubin P,
Tupchong L,
Brady LW,
Leibel SA,
Laramore GE,
Marcial VA,
Davis LW,
Cox JD,
et al. Second malignancies in patients who have head and neck cancer: incidence,
effect on survival and implications based on the RTOG experience.
Int J
Radiat Oncol Biol Phys. 1989 Sep;17(3):449-56.
Lin K,
Patel SG,
Chu PY,
Matsuo JM,
Singh B,
Wong RJ,
Kraus DH,
Shaha AR,
Shah JP,
Boyle JO.
Second primary malignancy of the aerodigestive tract in patients treated
for cancer of the oral cavity and larynx.
Head
Neck. 2005 Dec;27(12):1042-8.
Bluhm EC, Ronckers C, Hayashi RJ, Neglia JP, Mertens AC, Stovall M, Meadows AT, Mitby PA, Whitton JA, Hammond S, Barker JD, Donaldson SS, Robison LL, Inskip PD. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2008 Apr 15;111(8):4014-21.
4. (Breast) (glucosinolates) Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res. 2007 Mar;55(3):224-36.
(flavonoids) Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2285-92.
Chen D, Landis-Piwowar KR, Chen MS, Dou QP. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res. 2007 Nov 21;9(6):R80.
(vitamin D) Vijayakumar S, Boerner PS, Mehta RR, Packianathan S, Mehta RG, Das Gupta TK. Clinical trials using chemopreventive vitamin D analogs in breast cancer. Cancer J. 2006 Nov-Dec;12(6):445-50.
(tocopherols) Suh N, Paul S, Lee HJ, Ji Y, Lee MJ, Yang CS, Reddy BS, Newmark HL. Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats. Nutr Cancer. 2007;59(1):76-81.
(tocotrienols) Sylvester PW, Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J Clin Nutr. 2005;14(4):366-73.
(curcuminoids) Hammamieh R, Sumaida D, Zhang X, Das R, Jett M. Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer. 2007 Jul 25;7:138.
(green tea) Stuart EC, Rosengren RJ. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells. Life Sci. 2008 Apr 23;82(17-18):943-8.
(flax) Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005 May 15;11(10):3828-35.
5. (Prostate) (glucosinolates) Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007 Feb;232(2):227-34.
(isoflavones) Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer. 2008 May 11;8:132.
(flavonoid) Verschoyle RD, Greaves P, Patel K, Marsden DA, Brown K, Steward WP, Gescher AJ. Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels. Eur J Cancer. 2008 Apr;44(6):898-906.
(vitamin D) Schwartz GG. Vitamin D and Intervention Trials in Prostate Cancer: From Theory to Therapy. Ann Epidemiol. 2008 Jul 9. [Epub ahead of print]
(tocopherols) Wright ME, Weinstein SJ, Lawson KA, Albanes D, Subar AF, Dixon LB, Mouw T, Schatzkin A, Leitzmann MF. Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1128-35.
Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J, Albanes D. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst. 2005 Mar 2;97(5):396-9.
(selenium) Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003 May;91(7):608-12.
(organosulfurs) Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res. 2006 Nov 15;12(22):6836-43.
(carotenoids) Grainger EM, Schwartz SJ, Wang S, Unlu NZ, Boileau TW, Ferketich AK, Monk JP, Gong MC, Bahnson RR, DeGroff VL, Clinton SK. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer. 2008 Mar-Apr;60(2):145-54.
6. (Lung) (glucosinolates) Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci. 2007 May;64(9):1105-27.
(flavonoids)
Sadava
D, Whitlock E, Kane SE. The green tea polyphenol,
epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in
drug-resistant lung cancer cells. Biochem Biophys Res Commun. 2007 Aug 17;360(1):233.
Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr, Scrafford CG, Barraj LM, Mink PJ, Robien K. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer. 2008 Aug 1;123(3):664-71.
(vitamin A) Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients. J Surg Oncol. 1998 Aug;68(4):231-6.
Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N, Clerici M, Soresi E, Valente M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol. 1993 Jul;11(7):1216-22.
(vitamin D) Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007 Feb 10;25(5):479-85.
7.
(Melanoma) (flavonoids)
Conesa CM,
Ortega VV, Gascón MJY,
Baños MA, Jordana MC,
Benavente-García O, Castillo J.
Treatment of Metastatic Melanoma B16F10 by the Flavonoids Tangeretin, Rutin, and
Diosmin. J. Agric. Food Chem.,
53 (17), 6791 -6797, 2005.
(vitamin A) Naldi L, Gallus S, Tavani A, Imberti GL, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev. 2004 Dec;13(6):503-8.
(vitamin D) Nürnberg B, Schadendorf D, Gärtner B, Pföhler C, Herrmann W, Tilgen W, Reichrath J. Progression of malignant melanoma is associated with reduced 25-hydroxyvitamin D serum levels. Exp Dermatol. 2008 Jul;17(7):627.
(melanoma) Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer. 2005 Aug 15;104(4):879-90.
(green tea) Kang TH, Lee JH, Song CK, Han HD, Shin BC, Pai SI, Hung CF, Trimble C, Lim JS, Kim TW, Wu TC. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res. 2007 Jan 15;67(2):802-11.
8. (Pancreatic) (isoflavones) Büchler P, Reber HA, Büchler MW, Friess H, Lavey RS, Hines OJ. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer. 2004 Jan 1;100(1):201-10.
(vitamin D) Stolzenberg-Solomon RZ. Vitamin D and Pancreatic Cancer. Ann Epidemiol. 2008 May 24. [Epub ahead of print]
(curcuminoids) Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer. Clin Cancer Res. 2008 Jul 15;14(14):4491-4499.
(green tea) Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 2008 Jan 1;13:440-52.
9. (Colon) (glucosinolates) Pappa G, Strathmann J, Löwinger M, Bartsch H, Gerhäuser C. Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro. Carcinogenesis. 2007 Jul;28(7):1471-7.
(flavonoids) Hoensch H, Groh B, Edler L, Kirch W. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J Gastroenterol. 2008 Apr 14;14(14):2187-93.
(vitamin D) Soerjomataram I, Louwman WJ, Lemmens VE, Coebergh JW, de Vries E. Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol. 2008 Jun 15;167(12):1421-9.
(tocopherols) Stone WL, Krishnan K, Campbell SE, Qui M, Whaley SG, Yang H.
Tocopherols and the treatment of
colon cancer. Ann N Y Acad
Sci. 2004 Dec;1031:223-33.
Campbell S, Stone W, Whaley S, Krishnan K. Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent. Crit Rev Oncol Hematol. 2003 Sep;47(3):249-59.
(selenium) Marshall JR. Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am. 2008 Mar;37(1):73-82,
(curcuminoids/flavonoids) Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006 Aug;4(8):1035-8.
(curcuminoids) Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001 Jul;7(7):1894-900.
(green tea) Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Green tea polyphenols in the prevention of colon cancer. Front Biosci. 2007 Jan 1;12:2309-15.
(organosulfur) Ngo SN, Williams DB, Cobiac L, Head RJ. Does garlic reduce risk of colorectal cancer? A systematic review. J Nutr. 2007 Oct;137(10):2264-9.
Chan AS, Cheung MC, Law SC, Chan JH.
Phase II
study of alpha-tocopherol in improving the cognitive function of patients with
temporal lobe radionecrosis. Cancer.
2004 Jan 15;100(2):398-404.
Schwartzbaum JA, Cornwell DG.
Oxidant
stress and glioblastoma multiforme risk: serum antioxidants, gamma-glutamyl
transpeptidase, and ferritin. Nutr Cancer.
2000;38(1):40-9.
(selenium) Rooprai HK, Kyriazis I, Nuttall RK, Edwards DR, Zicha D, Aubyn D, Davies D, Gullan R, Pilkington GJ. Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
Sundaram N, Pahwa AK, Ard MD, Lin N, Perkins E, Bowles AP Jr. Selenium causes growth inhibition and apoptosis in human brain tumor cell lines. J Neurooncol. 2000;46(2):125-33.
11.
(Ovarian) (flavonoids) Luo H, Jiang
BH, King SM, Chen YC.
Inhibition of cell growth and VEGF expression in ovarian cancer cells by
flavonoids. Nutr Cancer.
2008;60(6):800-9.
Hu XW, Meng D, Fang J.
Apigenin
inhibited migration and invasion of human ovarian cancer A2780 cells through
focal adhesion kinase. Carcinogenesis.
2008 Dec;29(12):2369-76.
Zhou L, Liu P, Chen B, Wang Y, Wang X, Internati
MC, Wachtel MS, Frezza EE.
Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian
carcinoma cells. Anticancer Res.
2008 Mar-Apr;28(2A):1119-27.
(isoflavones)
Thasni KA, Rojini G, Rakesh SN, Ratheeshkumar T, Babu MS, Srinivas G,
Banerji A, Srinivas P.
Genistein induces apoptosis in ovarian cancer cells via different molecular
pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
Eur J Pharmacol. 2008 Jul 7;588(2-3):158-64.
Gossner G, Choi M, Tan L, Fogoros S, Griffith KA,
Kuenker M, Liu JR.
Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
Gynecol Oncol. 2007 Apr;105(1):23-30.
Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie
DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross
RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL.
Diet and
risk of ovarian cancer in the California Teachers Study cohort.
Am J Epidemiol. 2007 Apr 1;165(7):802-13.
Klein A, He X, Roche M, Mallett A, Duska L, Supko
JG, Seiden MV.
Prolonged stabilization of platinum-resistant ovarian cancer in a single patient
consuming a fermented soy therapy. Gynecol
Oncol. 2006 Jan;100(1):205-9.
(green tea)
Zhang M, Lee AH, Binns CW, Xie X.
Green
tea consumption enhances survival of epithelial ovarian cancer.
Int J Cancer.
2004 Nov
10;112(3):465-9.
Spinella F, Rosanò L, Di Castro V, Decandia S, Albini A, Nicotra MR,
Natali PG, Bagnato A.
Green
tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and
downstream signaling pathways in ovarian carcinoma.
Mol Cancer Ther. 2006 Jun;5(6):1483-92.
Spinella F, Rosanò L, Decandia S, Di Castro V,
Albini A, Elia G, Natali PG, Bagnato A.
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian
carcinoma cells: evidence for the endothelin-1 as a potential target.
Exp Biol Med (Maywood). 2006 Jun;231(6):1123-7.
Lee AH, Fraser ML, Binns CW.
Possible
role for green tea in ovarian cancer prevention.
Future Oncol. 2005 Dec;1(6):771-7.
Larsson SC, Wolk A.
Tea
consumption and ovarian cancer risk in a population-based cohort.
Arch Intern Med. 2005 Dec 12-26;165(22):2683-6.
12.
(Endometrial) (glucosinolates) van Poppel G, Verhoeven DT, Verhagen H, Goldbohm RA.
Brassica
vegetables and cancer prevention. Epidemiology and mechanisms.
Adv Exp Med Biol. 1999;472:159-68.
(isoflavones) Pfeiffer E, Graf E, Gerstner S,
Metzler M.
Stimulation of estradiol glucuronidation: a protective mechanism against
estradiol-mediated carcinogenesis? Mol Nutr
Food Res. 2006 Apr;50(4-5):385-9.
Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH,
Kolonel LN.
Association of soy and fiber consumption with the risk of endometrial cancer.
Am J Epidemiol. 1997 Aug 15;146(4):294-306.
Xu WH, Zheng W, Cai Q, Cheng JR, Cai H, Xiang YB,
Shu XO.
The
Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the
association of soy food and tea intake with endometrial cancer risk.
Nutr Cancer. 2008;60(6):736-43.
Xu WH, Dai Q, Xiang YB, Long JR, Ruan ZX, Cheng
JR, Zheng W, Shu XO.
Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms
in the development of endometrial cancer.
Am J Epidemiol. 2007 Dec 15;166(12):1420-30.
(vitamin A)
Ito K, Utsunomiya H, Yaegashi N, Sasano H.
Biological roles of estrogen and progesterone in human endometrial
carcinoma--new developments in potential endocrine therapy for endometrial
cancer. Endocr J. 2007
Dec;54(5):667-79.
Carter CA.
Retinoic
acid signaling through PI 3-kinase induces differentiation of human endometrial
adenocarcinoma cells. Exp Mol Pathol.
2003 Aug;75(1):34-44.
(vitamin D)
Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC.
Is
ultraviolet B irradiance inversely associated with incidence rates of
endometrial cancer: an ecological study of 107 countries.
Prev Med. 2007 Nov;45(5):327-31.
Salazar-Martinez E, Lazcano-Ponce E, Sanchez-Zamorano LM, Gonzalez-Lira
G, Escudero-DE Los Rios P, Hernandez-Avila M.
Dietary
factors and endometrial cancer risk. Results of a case-control study in Mexico.
Int J Gynecol Cancer. 2005
Sep-Oct;15(5):938-45.
Yabushita H, Hirata M, Noguchi M, Nakanishi M.
Vitamin
D receptor in endometrial carcinoma and the differentiation-inducing effect of
1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines.
J Obstet Gynaecol Res. 1996 Dec;22(6):529-39.
13.
(Leukemia) (vitamin A)
Niles RM.
Signaling pathways in retinoid chemoprevention and treatment of cancer.
Mutat Res. 2004 Nov 2;555(1-2):81-96.
Niles RM.
Recent advances in the use of vitamin A (retinoids) in the prevention and
treatment of cancer. Nutrition.
2000; 11(16):1084-9.
14.
(Lymphoma)
(isoflavones) Liu HL, Chen Y, Cui GH, Wu QL, He J.
Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on
human Burkitt's lymphoma Daudi cells in vitro.
Acta Pharmacol Sin. 2005 Jul;26(7):873-80.
Park SS, Kim YN, Jeon YK, Kim YA, Kim JE, Kim H,
Kim CW.
Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell
lymphoma. Cancer Chemother Pharmacol.
2005 Sep;56(3):271-8.
Baxa DM, Yoshimura FK.
Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage
of I kappa B alpha. Biochem Pharmacol.
2003 Sep 15;66(6):1009-18.
(vitamin D) Armstrong BK, Kricker A..
Sun
exposure and non-Hodgkin lymphoma. Cancer
Epidemiol Biomarkers Prev. 2007 Mar;16(3):396-400.
Porojnicu A, Robsahm TE, Berg JP, Moan J.
Season
of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be
involved: a possible role of sun-induced Vitamin D.
Steroid Biochem Mol Biol. 2007
Mar;103(3-5):675-8.
Chang ET, Bälter KM, Torrång A, Smedby KE, Melbye
M, Sundström C, Glimelius B, Adami HO.
Nutrient
intake and risk of non-Hodgkin's lymphoma.
Am J Epidemiol. 2006 Dec 15;164(12):1222-32.
Polesel J, Talamini R, Montella M, Parpinel M,
Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S.
Linoleic
acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma:
an Italian case-control study. Ann Oncol.
2006 Apr;17(4):713-8.
(selenium) Asfour IA, El-Tehewi MM, Ahmed MH,
Abdel-Sattar MA, Moustafa NN, Hegab HM, Fathey OM.
High-dose sodium selenite can induce apoptosis of lymphoma cells in adult
patients with non-Hodgkin's lymphoma. Biol
Trace Elem Res. 2009 Mar;127(3):200-10.
Last KW, Cornelius V, Delves T, Sieniawska C,
Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner AZ, Lister TA.
Presentation serum selenium predicts for overall survival, dose delivery, and
first treatment response in aggressive non-Hodgkin's lymphoma.
J Clin Oncol. 2003 Jun 15;21(12):2335-41.
Güven M, Oztürk B, Sayal A, Ozet A.
Lipid
peroxidation and antioxidant system in the blood of patients with Hodgkin's
disease. Clin Biochem. 2000
Apr;33(3):209-12.